Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kefumei is a flagship functional skincare brand developed by Giant Biogene, centered on proprietary recombinant collagen technology, specifically "human-like collagen" (HLC). Produced via synthetic biology and high-density fermentation, this recombinant protein is designed to be structurally identical to human collagen, offering superior biocompatibility, lower immunogenicity, and better water solubility compared to traditional animal-derived collagen. The Kefumei product line includes medical-grade dressings, which are registered as Class II medical devices in China, as well as consumer skincare products like masks, serums, and creams. These products are primarily used for skin barrier repair, soothing sensitive skin, and accelerating recovery following dermatological procedures such as laser therapy or chemical peels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kefumei.